Colonics
About Me
Recent Posts
- New RNA Processing Mechanism And A New Class Of Small RNAs Uncovered By Scientists At CSHL
- Mechanism Linking Serotonin With Regulation Of Food Intake Revealed By Research
- Study Identifies Genetic Variants Giving Rise To Differences In Metabolism
- AHF: Lancet’s Africa AIDS study shows global testing woefully under-funded
- World Gathers In Brazil To Reinvigorate Fight Against Sexual Exploitation Of Children
Menu
Calendar
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 | ||||
Friends
Links
Entry 1 of 445
Last Page | Next Page
9/15/2008
-
FDA grants approval to Talecris Biotherapeutics for Gamunex for neurological disorder CIDP
|
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug supervision (FDA) has granted sanction for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a therapy intensive rehabilitationpatient centred programs for spinal cord for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological mix up that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills. More: - The rest... |
Post A Comment! :: Send to a Friend! |
Share and enjoy
